Cargando…
A meta-analysis of nivolumab for the treatment of advanced non-small-cell lung cancer
BACKGROUND: Non-small-cell lung cancer (NSCLC) is often associated with rapid progression following standard chemotherapy. Nivolumab, an inhibitor of PD-1/PD-L1, is reported to have potential efficacy for the treatment NSCLC. OBJECTIVE: The purpose of this meta-analysis was to systematically evaluat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217212/ https://www.ncbi.nlm.nih.gov/pubmed/30464517 http://dx.doi.org/10.2147/OTT.S171072 |